4

PRIMARY DOCUMENT

Company: ENDONOVO THERAPEUTICS, INC.
Filed: October 15, 2019
Period of Report: October 2, 2019
Accession Number: 0001645470-19-000052

View Document ↗ View on SEC.gov ↗